About 288 results
Tepotinib is a novel precision cancer medicine capable of targeting NSCLC with MET 14 exon skipping alterations
Research suggests Metformin a widely used diabetic drug combined with a TKI may improve survival of EGFR mutated NSCLC.
Answers to frequently asked questions about Ovarian Germ Cell cancers
The 2nd generation TKI flumatinib appears to control CP-CML better than the historical standard of Gleevec.
First degree relatives of individuals with Melanoma are at increased risk of developing skin cancers.
Surgery, RFA, precision cancer medicines & immunotherapy all play a role in the optimal treatment of kidney cancer.
Precision cancer medicines and targeted immunotherapy are increasingly used or the treatment of thyroid cancer.
Cachexia in cancer patients is characterized by progressive loss of appetite and muscle mass with few treatment options.
Research suggests high dose vitamin D supplements may reduce bone density loss from AI drugs used to treat breast cancer
Ripretinib is a next generation kinase inhibitor that appears promising for treatment of GIST